These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35323078)

  • 1. Understanding the Patient PPI Journey: Results of a Survey on PPI Treatment Initiation and Patient Experience.
    Plehhova K; Paquette N; Gould J; Coyle C
    J Prim Care Community Health; 2022; 13():21501319221088688. PubMed ID: 35323078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
    Toghanian S; Johnson DA; Stålhammar NO; Zerbib F
    Clin Drug Investig; 2011 Oct; 31(10):703-15. PubMed ID: 21756007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?
    Ghosh G; Schnoll-Sussman F; Mathews S; Katz PO
    Aliment Pharmacol Ther; 2020 Jan; 51(1):121-128. PubMed ID: 31664732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
    Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
    Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
    Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We have had a gutful: The need for deprescribing proton pump inhibitors.
    Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
    J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit.
    Joret-Descout P; Dauger S; Bellaiche M; Bourdon O; Prot-Labarthe S
    Int J Clin Pharm; 2017 Feb; 39(1):181-186. PubMed ID: 28093644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of gastro-oesophageal reflux disease-treatment costs, safety profile, and effectiveness: a narrative review.
    Lata T; Trautman J; Townend P; Wilson RB
    Gastroenterol Rep (Oxf); 2023; 11():goad008. PubMed ID: 37082451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
    Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
    Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.